Sands Capital Ventures Discovery Fund Iii, L.P. Acumen Pharmaceuticals, Inc. (ABOS) insider trading activity

ABOS Quotes by TradingView

Sands Capital Ventures Discovery Fund Iii, L.P. is > 10% Shareholder of Acumen Pharmaceuticals, Inc.. Currently has a direct ownership of 3.42 Million shares of ABOS, which is worth approximately $8.1 Million. The most recent transaction as insider was on Jul 06, 2021, when has been sold 450,000 shares (Common Stock) at a price of $14.88 per share, resulting in proceeds of $6,696,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.42M
0% 3M change
0% 12M change
Total Value Held $8.1 Million

Sands Capital Ventures Discovery Fund III, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 06 2021
BUY
Open market or private purchase
$6,696,000 $14.88 p/Share
450,000 Added 11.64%
3,417,075 Common Stock
Jul 06 2021
BUY
Conversion of derivative security
-
2,967,075 Added 50.0%
2,967,075 Common Stock
SCV

Sands Capital Ventures Discovery Fund Iii, L.P.

> 10% Shareholder
Arlington, VA

Track Institutional and Insider Activities on ABOS

Follow Acumen Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABOS shares.

Notify only if

Insider Trading

Get notified when an Acumen Pharmaceuticals, Inc. insider buys or sells ABOS shares.

Notify only if

News

Receive news related to Acumen Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ABOS